139 related articles for article (PubMed ID: 35209701)
1. Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
Dechaphunkul A; Thongwatchara P; Thongsuksai P; Dechaphunkul T; Geater SL
J Pathol Transl Med; 2022 May; 56(3):126-133. PubMed ID: 35209701
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
Theurer JA; Stecho W; Yoo J; Kwan K; Wehrli B; Harry V; Black M; Pinto N; Winquist E; Palma D; Richter S; Barrett JW; Danielle MacNeil S; Fung K; Howlett CJ; Nichols AC
Pathol Oncol Res; 2016 Jan; 22(1):35-40. PubMed ID: 26271341
[TBL] [Abstract][Full Text] [Related]
6. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
[TBL] [Abstract][Full Text] [Related]
7. Detection of
Borkowska EM; Barańska M; Kowalczyk M; Pietruszewska W
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072735
[TBL] [Abstract][Full Text] [Related]
8. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.
McBride SM; Rothenberg SM; Faquin WC; Chan AW; Clark JR; Ellisen LW; Wirth LJ
Head Neck; 2014 Aug; 36(8):1181-8. PubMed ID: 23852799
[TBL] [Abstract][Full Text] [Related]
9. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
[TBL] [Abstract][Full Text] [Related]
10. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
[TBL] [Abstract][Full Text] [Related]
11. Association of PIK3CA gene mutations with head and neck squamous cell carcinomas.
Kommineni N; Jamil K; Pingali UR; Addala L; M V; Naidu M
Neoplasma; 2015; 62(1):72-80. PubMed ID: 25563369
[TBL] [Abstract][Full Text] [Related]
12. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
[TBL] [Abstract][Full Text] [Related]
13. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
Qiu W; Tong GX; Manolidis S; Close LG; Assaad AM; Su GH
Int J Cancer; 2008 Mar; 122(5):1189-94. PubMed ID: 17990317
[TBL] [Abstract][Full Text] [Related]
14.
Kusaba Y; Kajihara I; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Sawamura S; Makino K; Aoi J; Masuguchi S; Fukushima S
Intractable Rare Dis Res; 2023 Aug; 12(3):206-207. PubMed ID: 37662619
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma.
Zhang L; Shi L; Zhao X; Wang Y; Yue W
Onco Targets Ther; 2013; 6():497-502. PubMed ID: 23674897
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
17. TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma.
van Kempen PM; Verdam FJ; de Poel E; Braunius WW; de Weger RA; van Es RJ; Grolman W; Willems SM
Pathobiology; 2015; 82(1):21-27. PubMed ID: 25765855
[TBL] [Abstract][Full Text] [Related]
18. [Screening for mutations in the hotspot mutation regions of PIK3CA gene in nasopharyngeal carcinoma].
Liu P; Li DJ; Qin HD; Zhang RH; Chen LZ; Zeng YX
Ai Zheng; 2007 Jan; 26(1):15-20. PubMed ID: 17222361
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer.
Schmidt H; Kulasinghe A; Allcock RJN; Tan LY; Mokany E; Kenny L; Punyadeera C
Diagnostics (Basel); 2018 Nov; 8(4):. PubMed ID: 30501041
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]